Annual Drug Patent Expirations for BEPREVE
Bepreve is a drug marketed by Bausch And Lomb Inc and is included in one NDA. It is available from two suppliers. There are two patents protecting this drug and one Paragraph IV challenge.
Drug patent litigation for BEPREVE.
This drug has eleven patent family members in eight countries.
The generic ingredient in BEPREVE is bepotastine besilate. Two suppliers are listed for this compound. Additional details are available on the bepotastine besilate profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com